Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence
- PMID: 24852287
- PMCID: PMC7965302
- DOI: 10.3174/ajnr.A3917
Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence
Abstract
The aim of this article was to review the properties of the various gadolinium-based contrast agents used for CNS imaging along with the clinical evidence and published data that highlight the impact these different properties can have on diagnostic performance. In addition, approaches to optimizing image acquisition that take into account the different properties of specific gadolinium-based contrast agents and an extensive review of the safety profiles of the various agents are presented.
© 2014 by American Journal of Neuroradiology.
Figures
Similar articles
-
Synthesizing a Contrast-Enhancement Map in Patients with High-Grade Gliomas Based on a Postcontrast MR Imaging Quantification Only.AJNR Am J Neuroradiol. 2018 Dec;39(12):2194-2199. doi: 10.3174/ajnr.A5870. Epub 2018 Nov 8. AJNR Am J Neuroradiol. 2018. PMID: 30409854 Free PMC article.
-
Advances in magnetic resonance (2008).Invest Radiol. 2008 Dec;43(12):893-8. doi: 10.1097/RLI.0b013e31818e659e. Invest Radiol. 2008. PMID: 19002061 Review.
-
Effect of Gadolinium on the Estimation of Myelin and Brain Tissue Volumes Based on Quantitative Synthetic MRI.AJNR Am J Neuroradiol. 2019 Feb;40(2):231-237. doi: 10.3174/ajnr.A5921. Epub 2018 Dec 27. AJNR Am J Neuroradiol. 2019. PMID: 30591507 Free PMC article.
-
Perfusion MRI: the five most frequently asked clinical questions.AJR Am J Roentgenol. 2013 Sep;201(3):W495-510. doi: 10.2214/AJR.12.9544. AJR Am J Roentgenol. 2013. PMID: 23971482 Free PMC article. Review.
-
Unilateral Nonvisualization of a Transverse Dural Sinus on Phase-Contrast MRV: Frequency and Differentiation from Sinus Thrombosis on Noncontrast MRI.AJNR Am J Neuroradiol. 2020 Jan;41(1):115-121. doi: 10.3174/ajnr.A6337. AJNR Am J Neuroradiol. 2020. PMID: 31924604 Free PMC article.
Cited by
-
Diffusion Tensor Imaging of the Dentate Nucleus After Repeated Administration of Gadobutrol in Children.Cerebellum. 2022 Aug;21(4):657-664. doi: 10.1007/s12311-021-01324-w. Epub 2021 Aug 27. Cerebellum. 2022. PMID: 34453283
-
Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI.J Cardiovasc Magn Reson. 2016 Nov 18;18(1):84. doi: 10.1186/s12968-016-0302-x. J Cardiovasc Magn Reson. 2016. PMID: 27855705 Free PMC article.
-
Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects.Br J Clin Pharmacol. 2020 Nov;86(11):2174-2181. doi: 10.1111/bcp.14309. Epub 2020 Apr 27. Br J Clin Pharmacol. 2020. PMID: 32302009 Free PMC article. Clinical Trial.
-
Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Br J Radiol. 2015 Apr;88(1048):20140526. doi: 10.1259/bjr.20140526. Epub 2015 Feb 4. Br J Radiol. 2015. PMID: 25651409 Free PMC article. Clinical Trial.
-
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16. AJNR Am J Neuroradiol. 2015. PMID: 26185325 Free PMC article. Clinical Trial.
References
-
- Dotarem product label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204781s000lbl.pdf. Accessed May 10, 2013.
-
- Gadavist product label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201277s000lbl.pdf. Accessed May 10, 2013.
-
- Magnevist product label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019596s051lbl.pdf. Accessed May 10, 2013.
-
- MultiHance product label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021357s009lbl.pdf. Accessed May 10, 2013.
-
- Omniscan product label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020123s037lbl.pdf. Accessed May 10, 2013.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical